Product details
Catalog number #40056-T
Price for #40056-T
Size / count 1x 5 nmol
CF® dye dCTP can be used to synthesize labeled DNA probes for in situ hybridization, microarray or blotting applications. CF® dyes are Biotium's line of next-generation fluorescent dyes with advantages in brightness, photostability, and conjugate specificity compared to other fluorescent dyes. Deep-red fluorescent CF®594 dye has excitation/emission at 593/614 nm.
The catalog number for CF®594 dCTP, Lyophilized powder is #40056-T.
CF®594 dCTP, Lyophilized powder is available in the following size(s): 1x 5 nmol.
CF®594 dCTP, Lyophilized powder is currently made to order / not held in immediate stock. Contact us for lead time.
CF®594 dCTP, Lyophilized powder is manufactured by Biotium.
Estimated delivery time for CF®594 dCTP, Lyophilized powder is approximately 15 business day(s), depending on your location.
The safety data sheet for CF®594 dCTP, Lyophilized powder is available here: https://cdn.gentaur.com/products/37/699c39d30d8c9d341e1648fe/msds/%2340056-t.pdf.
CF® dye dCTP can be used to synthesize labeled DNA probes for in situ hybridization, microarray or blotting applications. CF® dyes are Biotium's line of next-generation fluorescent dyes with advantages in brightness, photostability, and conjugate specificity compared to other fluorescent dye
Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.
The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.
As a consumer, you have a 14-day right of withdrawal from receipt under EU consumer protection law, submitted via our withdrawal/cancellation request form. Note this applies to unused, undamaged products, and doesn’t override the expiry/storage conditions on performance-based claims.